Factory-on-a-Chip Microfluidics for Cell-Free Biotherapeutic Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biotherapeutic manufacturing processes are large-scale, costly, and not suitable for point-of-care applications due to low protein yield and lack of miniaturization and automation, necessitating a flexible, scalable, and portable system for on-demand production.
Innovation Solution
A fully integrated microfluidic system, or 'factory-on-a-chip', comprising a bioreactor unit, mixer/debubbler, and purification unit with chromatography columns, enabling continuous-flow production of biotherapeutics at the microscale using a cell-free reaction system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If large-scale fermentation batches are used for biotherapeutic production, then production capacity is improved, but device complexity and cost increase significantly
Solution Approach 1:
The patent divides the large-scale fermentation process into multiple small-scale microreactors (e.g., 5-50 mL volume each), allowing the system to achieve high total productivity through parallel processing while maintaining simple, manageable individual units that can be easily scaled by adding more modules rather than managing a single complex large-scale system
Solution Approach 2:
Multiple microreactor modules are combined in parallel within a single system, each performing the same protein production function independently. This merging approach achieves the productivity of large-scale fermentation while keeping each individual reactor simple and the overall system manageable through modular architecture
2Productivity
If cell-based systems are used for biotherapeutic production, then protein yield is improved, but loss of time increases due to longer production cycles
Solution Approach 1:
The patent extracts and removes the cellular components (cells, organelles, membranes) from the protein production system, using only the essential cellular machinery (ribosomes, enzymes, factors) in a cell-free extract. This extraction eliminates the time required for cell growth, maintenance, and harvesting while preserving the protein synthesis capability, thereby reducing production time without sacrificing protein yield
Solution Approach 2:
The cellular machinery is pre-prepared and pre-processed into a ready-to-use extract before the actual protein production begins. This preliminary preparation of the cell-free extract eliminates the need for time-consuming in-situ cell culture and processing steps during the protein production phase, enabling faster turnaround times
3Volume of moving object
If miniaturization is implemented for point-of-care applications, then device portability is improved, but manufacturing precision requirements increase
Solution Approach 1:
The patent employs disposable microreactor modules and single-use consumables that can be manufactured using standard, relatively simple fabrication techniques. The low cost and disposable nature of these components reduces the pressure for ultra-high manufacturing precision, as each module can be independently manufactured and replaced without requiring complex retooling or extremely tight tolerance specifications across production batches
4Manufacturing precision
If automated purification systems are implemented, then manufacturing precision is improved, but device complexity increases
Solution Approach 1:
The patent incorporates self-service features where the microreactor system automatically performs purification steps through integrated filtration membranes, centrifugal separation, or affinity chromatography columns that self-regulate based on flow conditions. The system automatically separates and concentrates the target protein without requiring complex external automation equipment, maintaining high purification quality while minimizing added system complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables on-demand production and delivery of therapeutic proteins within one hour to one day, maintaining protein potency and viability, suitable for point-of-care administration in portable units like ambulances or battlefields.
Implementation Method 1
a microfluidic bioreactor unit equipped with a continuous collection channel for synthesizing a crude protein in a reaction within the microfluidic bioreactor
Implementation Method 2
a microfluidic purification unit communicatively connected to the microfluidic mixer/de-bubbler unit comprising at least one purification column for capturing the crude protein
Implementation Method 3
sensors for monitoring pH, ionic strength, UV-Vis absorbance, fluorescence, light scatter and or circular dichroism for testing of the purified protein
Data Source
AI summary
The present invention provides for a fully integrated microfluidic system capable of producing single-dose amounts of biotherapeutics at the point-of-care wherein protein production, purification and product harvest are all integrated as a single microfluidic device which is portable and capable of continuous-flow production of biotherapeutics at the microscale using a cell-free reaction system.